2024 NOSCM | Targeted Therapy in Hema Malignancies (CD20, CD30, CD33, BCR/ABL, FLT3, IDH1/2)
0% Complete
Course Content
This material is non-CME, no credits are available, and a certificate will not be provided upon completion.
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Faculty & Disclosure
Faculty
Brian Primeaux, PharmD, BCOP
Disclosure
Brian Primeaux, PharmD, BCOP discloses no such relationships exist
Accreditation
NA
-1769197262927.webp&w=3840&q=75)
-1769197177699.webp&w=3840&q=75)